The sirtuin family in health and disease

QJ Wu, TN Zhang, HH Chen, XF Yu, JL Lv… - … and Targeted Therapy, 2022 - nature.com
Sirtuins (SIRTs) are nicotine adenine dinucleotide (+)-dependent histone deacetylases
regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in …

Pathological mechanisms and therapeutic outlooks for arthrofibrosis

KM Usher, S Zhu, G Mavropalias, JA Carrino, J Zhao… - Bone research, 2019 - nature.com
Arthrofibrosis is a fibrotic joint disorder that begins with an inflammatory reaction to insults
such as injury, surgery and infection. Excessive extracellular matrix and adhesions contract …

From NAFLD to MAFLD: implications of a premature change in terminology

ZM Younossi, ME Rinella, AJ Sanyal, SA Harrison… - …, 2021 - Wiley Online Library
Despite the substantial gains in our understanding of NAFLD/NASH over the past 2
decades, there has been some dissatisfaction with the terminology “non‐alcoholic” which …

Research progress in the molecular mechanisms, therapeutic targets, and drug development of idiopathic pulmonary fibrosis

H Ma, X Wu, Y Li, Y Xia - Frontiers in Pharmacology, 2022 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Recent studies have
identified the key role of crosstalk between dysregulated epithelial cells, mesenchymal …

The crosstalk between Nrf2 and NF-κB pathways in coronary artery disease: Can it be regulated by SIRT6?

E Casper - Life sciences, 2023 - Elsevier
Coronary artery disease (CAD) is the leading cause of death worldwide. Oxidative stress
and inflammation are major mechanisms responsible for the progression of CAD. Nuclear …

[PDF][PDF] Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells

J Zhang, Y Li, Q Liu, Y Huang, R Li, T Wu, Z Zhang… - …, 2021 - Wiley Online Library
Backgrounds and Aims Activation of hepatic stellate cells (HSCs) is a central driver of
fibrosis. This study aimed to elucidate the role of the deacetylase sirtuin 6 (Sirt6) in HSC …

TGF‑β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis

Z Ye, Y Hu - International journal of molecular …, 2021 - spandidos-publications.com
Idiopathic pulmonary fibrosis (IPF) is a worldwide disease characterized by the chronic and
irreversible decline of lung function. Currently, there is no drug to successfully treat the …

[HTML][HTML] SIRT6 in aging, metabolism, inflammation and cardiovascular diseases

Z Guo, P Li, J Ge, H Li - Aging and disease, 2022 - ncbi.nlm.nih.gov
As an important NAD+-dependent enzyme, SIRT6 has received significant attention since its
discovery. In view of observations that SIRT6-deficient animals exhibit genomic instability …

Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis

S Mahalanobish, S Saha, S Dutta, PC Sil - Pharmacological Research, 2020 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a debilitating condition where excess collagen
deposition occurs in the extracellular matrix. At first sight, it is expected that the level of …

Lipid peroxidation and GPX4 inhibition are common causes for myofibroblast differentiation and ferroptosis

Y Gong, N Wang, N Liu, H Dong - DNA and Cell Biology, 2019 - liebertpub.com
Ferroptosis is a new form of regulated cell death. Fibroblast-to-myofibroblast differentiation is
known to be involved in the pathogenesis of idiopathic pulmonary fibrosis. Utilizing HFL1 …